For decades, we have leveraged our world-class expertise in medicinal chemistry and biology to discover, develop and deliver medicines that offer patients new treatment options.
Hematology
Hematology is central to the identity of Incyte. We are a leader in the discovery and development of therapies for patients with myeloproliferative neoplasms (MPNs) and graft-versus-host disease (GVHD). Building on this legacy, we are developing mutation-specific targeted therapies across the full MPN spectrum that have the potential to transform treatment for patients.
Oncology
Despite progress, cancer continues to be a leading cause of death worldwide, impacting millions of people. Given the significant unmet medical need, we are advancing research in areas where we believe we can have the greatest impact.
Our focus is on novel biologic targets and pathways in high incidence cancers, and we are exploring both single agents and combinations of targeted and immuno-therapies from both within and beyond our portfolio.
Approved Therapies
Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you are seeking medical information on our products, or wish to meet with a Medical Science Liaison, please visit IncyteMI.com.
To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463).
.png){kind=logo}
Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you need medical information or have a medical question, please visit incyteglobalmedicalinformation.com.
To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Global Medical Information.
Resources
FOR PATIENTS
Voices of MPN is an online platform that links people in the U.S. affected by myeloproliferative neoplasms (MPNs) to disease information, educational programs, helpful resources and tips and community activities.
TestMyCholangio is a website designed to educate patients in the U.S. with cholangiocarcinoma about molecular profiling and the role it may play in informing management decisions. Patients can find information and resources to encourage productive discussions with their healthcare professionals.
This site can help patients and caregivers understand graft-versus-host disease (GVHD) with information and resources to provide support along the road toward health after transplant.
Through IncyteCARES—a patient support and assistance program for eligible patients prescribed Jakafi, Pemazyre, Opzelura, Niktimvo, Monjuvi or Zynyz—we strive to implement initiatives that support patients and remove barriers to accessing these medicines in the U.S. Our team can help patients with understanding their insurance coverage, exploring financial assistance options and providing as-needed support.
Analcancer.com is designed to support patients and break down stigma associated with SCAC. It outlines risk factors and symptoms, elevates the science, amplifies patient stories and seeks to normalize anal cancer terminology to ease conversations around this cancer.
FOR HEALTHCARE PROFESSIONALS
From articles and diagnostic tools to videos and podcasts from industry leaders, MPN Connect offers a variety of professional resources about myeloproliferative neoplasms (MPNs)—including myelofibrosis, polycythemia vera and essential thrombocythemia.
Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you are seeking medical information on our products, or wish to meet with a Medical Science Liaison, please visit IncyteMI.com.
To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463).
FOR HEALTHCARE PROFESSIONALS
The Cholangiocarcinoma Europe website helps European healthcare professionals learn more about cholangiocarcinoma (CCA). CCAs are diverse biliary epithelial tumors involving the intrahepatic, perihilar and distal parts of the biliary tree. Each anatomical subtype has distinct epidemiology, molecular characteristics, prognosis and strategy for clinical management.
Incyte is committed to providing timely and accurate product information to healthcare professionals upon request. If you need medical information or have a medical question, please visit incyteglobalmedicalinformation.com.
To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Global Medical Information.